We are a neuroscience company forging a new direction to reduce the enormous burden of diseases that impact the nervous system. At our core, we unite biological insights with clinically meaningful solutions to build and catalyze a diversified portfolio of transformative medicines. Harnessing our rigorous scientific approach to identify the most promising therapies, we leverage our flexible transaction model to advance assets with validated mechanisms and efficiently move them through development to commercialization.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $253M
Founded date: 2019
Investors 5
| Date | Name | Website |
| 20.03.2024 | F-Prime Ca... | fprimecapi... |
| 23.03.2024 | Forbion | forbion.co... |
| 21.03.2024 | Ysios Capi... | ysioscapit... |
| 13.04.2024 | Red Tree V... | redtreevc.... |
| 21.03.2024 | Eight Road... | eightroads... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 21.03.2024 | Series B | $157M | F-Prime Ca... |
| 04.08.2021 | Series A | $64M | - |
| 25.06.2020 | Series A | $32M | - |
Mentions in press and media 17
| Date | Title | Description | Source |
| 21.03.2024 | Engrail Therapeutics Secures USD 157 Mn in Series B from F-P... | - | entreprene... |
| 20.03.2024 | Engrail Therapeutics Secures $157M in Series B Funding | Engrail Therapeutics, a precision neuroscience company based in San Diego, CA, has closed a $157M Se... | parsers.vc... |
| 20.03.2024 | Engrail Therapeutics Closes Oversubscribed $157M Series B Fi... | Proceeds to Support Advancement of Engrail's Pipeline for Neuropsychiatric and Neurodevelopmental Di... | en.prnasia... |
| 19.03.2024 | Engrail Therapeutics raises $157M Series B | Engrail Therapeutics, a precision neuroscience company focused on the development of transformationa... | eightroads... |
| 19.03.2024 | Engrail Therapeutics raises $157 million in funding from F-P... | - | fprimecapi... |
| 19.03.2024 | Engrail Therapeutics raises $157 million in funding from F-P... | Vikram Sudarsan, president and CEO of Engrail Therapeutics Engrail Therapeutics, a clinical stage co... | economicti... |
| 19.03.2024 | Engrail Therapeutics Closes $157M Series B Financing Round | Engrail Therapeutics, a San Diego, CA-based precision neuroscience company focused on the developmen... | finsmes.co... |
| 19.03.2024 | Forbion co-leads oversubscribed $157M Series B Financing Rou... | • Proceeds to Support Advancement of Engrail’s Pipeline for Neuropsychiatric and Neurodevelopmental ... | forbion.co... |
| 19.03.2024 | Engrail closes $157M series B, fueled by investors’ renewed ... | - | fprimecapi... |
| 18.08.2021 | US biotech company acquires NeuroCycle Therapeutics | startuptic... |
Show more